Le Lézard
Classified in: Science and technology
Subject: OBI

Renowned scientist and philanthropist Dr. Dmitry B. Zimin passes away peacefully at the age of 88 after a battle with cancer


MOSCOW, Dec. 24, 2021 /PRNewswire/ -- On Wednesday 22 December, Dr. Dmitry B. Zimin passed away peacefully at the age of 88 after a battle with cancer.

Dr. Dmitry Zimin, noted scientist and philanthropist (PRNewsfoto/The office of Dr. Zimin)

Dr. Zimin was a renowned Russian scientist, inventor, entrepreneur, and CEO. He was internationally recognised as a visionary pioneer who, through his philanthropic activities, dedicated his life and wealth to supporting science and education as key pillars of societal progress.

Dr. Zimin was one of the lead designers of Moscow's anti-ballistic missile defence radar system, and later founded VimpelCom, which was the first Russian company to be listed on the NYSE in 1996 and became one of the world's largest mobile operators. He championed scientists and supported their work and research by establishing the Dynasty Foundation and later the Zimin Foundation and the Zimin Institutes, which are located at various global universities.

Dr. Zimin was awarded the Russian Federation State Prize for his contribution to defence radar systems. He was the first and only Russian citizen to be awarded the Carnegie Medal of Philanthropy for his social investment work.

He was awarded an Honorary Doctorate by Tel Aviv University in Israel. Dr. Zimin was also given the Russian Ministry of Science and Education's award "For Commitment to Science".

Dr. Zimin created the prestigious literary award Premya Prosvetitel ("Enlightener Prize"), which annually awards prizes to the best authors of popular science books in the Russian language. He also established the Dynasty Library project to translate and publish over 100 international works on popular science.

Dr. Zimin always supported a free exchange of views and ideas. Through his philanthropy, he contributed to popularizing science, making it accessible and engaging to all citizens of the world, with the goal of improving the state of humanity through real-world innovation.

 

SOURCE The office of Dr. Zimin


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: